JALSG AML/MDS/CMML Clinical Observational Study(JALSG-CS-11-MDS-SCT)

JALSG AML/MDS/CMML Clinical Observational Study(JALSG-CS-11-MDS-SCT) - JALSG AML/MDS/CMML Clinical Observational Study(JALSG-CS-11-MDS-SCT)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036437

Enrollment

491

Registered

2019-04-07

Start date

2019-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MDS-RAEB/EB

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: MDS-RAEB/EB patients registered as JALSG-CS-11 between 2011 and 2016.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Overall survival by bridging therapy	—

Countries

Japan

Contacts

Public ContactKen Ishiyama

JALSG-CS-11-MDS-SC research secretariat Department of Hematology

ishiyama-knz@umin.ac.jp076-265-2274

Outcome results